RxDoctor Payments Data

Marsha Mitchell

Family · Hillsboro, OHNPI 1659502904

Payments from drug & device makers

$341in general payments, 2019–2025

Across 21 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$96
  • Abbott$50
  • Novo Nordisk$42
  • Lilly USA, LLC$39
  • Esperion Therapeutics, Inc.$30
  • Philips North America LLC$17
  • plus $66 from 5 others

What the payments were for

  • Food & beverage$341100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$341 in reported general payments places this provider in the 50th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$180
Medicare patients
14
Services billed
17

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide38$55,118
EliquisApixaban41$43,036
JardianceEmpagliflozin44$40,543
MounjaroTirzepatide23$30,002
RybelsusSemaglutide18$25,776
XareltoRivaroxaban18$23,129
TrulicityDulaglutide19$21,996
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$16,140
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$14,052
JanuviaSitagliptin Phosphate21$13,839
LyricaPregabalin12$10,737
Breo ElliptaFluticasone/Vilanterol16$10,343
LinzessLinaclotide20$10,218
TradjentaLinagliptin11$9,548
Spiriva HandihalerTiotropium Bromide16$9,053

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$42$80,89356 claims
Boehringer IngelheimJardiance, Tradjenta, Jentadueto$15$56,24267 claims
PfizerEliquis, Lyrica$12$53,77353 claims
Lilly USA, LLCMounjaro, Trulicity$39$51,99842 claims
AstraZenecaBreztri Aerosphere, Symbicort$12$16,68726 claims
AbbVieLinzess, Savella$96$16,67131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,812 family providers in Ohio.

Other family in Hillsboro

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →